Do you know what the MHRA requires of your radioisotope vial?
If you work in a UK facility preparing radiopharmaceutical doses for patient administration, then you are likely filling these doses into an internally sterile nitrogen filled vial. You may or may not be aware that this vial is officially a medical device, and as such must adhere to certain regulations for it to be used safely and legally.
This article aims to assist you in understanding what the MHRA mandates as necessary for medical devices and how you can ensure the vials you are using meet these requirements.
Use our free Supplier Evaluation Checklist to ensure your vials meet MHRA requirements.
A medical device is any instrument (other than a medicine) that is used to diagnose, monitor, treat or manage a medical condition (as defined by MDD Article 1.2a, MDR Article 2.1, UK MDR Part I Interpretations). Radiopharmacies use sterile nitrogen filled vials to hold doses of radioisotopes which are used for diagnosing and treating diseases such as cancer and kidney disease, and this is why they are deemed medical devices.
It is important to be aware that where a sterile vial is being sold as a medical device in the UK it must meet strict requirements and be registered with the relevant authorities. Historically this has meant complying with the EU MDD and having a CE Mark. Following Brexit, oversight of medical devices is transitioning to UK rule and will be covered by the UK MDR, and by 2030 all medical devices sold in the UK will need to be fully transitioned to the UK MDR and bear the new UKCA Mark.
Radiopharmacies and nuclear medicine departments using sealed vials for patient doses should ensure these containers meet the necessary requirements. In this article we explain what you need to look out for to ensure you’re compliant with UK law and are best protecting your patients.
Medical devices are required to bear relevant marking. During the transition from EU MDD to UK MDR, there are actually three conformity assessment routes which can be applied to medical devices to obtain either a UKCA or CE mark.
Here’s what you need to check depending on which mark your vial displays.
What you need:
What you need:
What you need:
The MHRA will only accept registration of devices from manufacturers where the legal manufacturer is based in the UK. Non-UK based manufacturers must appoint a UK responsible person. This UK responsible person will then assume responsibilities on behalf of the manufacturer including registering the device with the MHRA. Here’s what you need to know:
If the legal manufacturer of your sterile nitrogen filled vial is based in the UK, you should ensure they can demonstrate that they:
If the legal manufacturer of the vials is based outside of the UK, they should have everything a compliant UK manufacturer will have (see above), plus the following:
If the device is being placed on the market under CE certification the manufacturer must also:
The guidance in this article refers to the transitional period from EU to UK regulation. CE marking will no longer be recognised in the UK after 30th June 2028 (CE MDD) or 30th June 2030 (CE MDR) depending on the type of CE certificate held. After this point all medical devices sold into the UK must have a valid UKCA mark in accordance with the UK Medical Device Regulations.
We are pleased to confirm our Anoxos® sterile nitrogen filled vials comply with all UK MDR requirements and hold both CE and UKCA marks. You can access our CE (MDD), CE (MDR) and UKCA certificates on our website.
We appreciate this is a complex topic to navigate, and we’re here to support you should you need help understanding what is and isn’t compliant with MHRA requirements.
Please contact our expert team for advice: sales@adelphi-hp.com
For more information on the regulations surrounding medical devices being used in the UK, visit: https://www.gov.uk/guidance/regulating-medical-devices-in-the-uk#legislation-that-applies-in-great-britain
Use our free Supplier Evaluation Checklist to ensure your vials meet MHRA requirements:
Download PDF